Beacon Biosignals is mapping the brain during sleep
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.
An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.
Read MoreAssistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Read MoreDriven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Read MoreOpening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
Read MoreProfessor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Read MoreNew research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy.
Read MoreNew research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
Read MoreLarge language models can learn to mistakenly link certain sentence patterns with specific topics — and may then repeat these patterns instead of reasoning.
Read MoreMIT PhD students who interned with the MIT-IBM Watson AI Lab Summer Program are pushing AI tools to be more flexible, efficient, and grounded in truth.
Read More
You must be logged in to post a comment.